Cargando…
Can Gene Therapy Be Used to Prevent Cancer? Gene Therapy for Aldehyde Dehydrogenase 2 Deficiency
Approximately 8% of the world population and 35 to 45% of East Asians are carriers of the hereditary disorder, aldehyde dehydrogenase 2 (ALDH2) deficiency. ALDH2 plays a central role in the liver to metabolize ethanol. With the common E487K variant, there is a deficiency of ALDH2 function; when etha...
Autores principales: | Montel, Rachel A., Zuluaga, Carlos Munoz, Stiles, Katie M., Crystal, Ronald G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117562/ https://www.ncbi.nlm.nih.gov/pubmed/34799722 http://dx.doi.org/10.1038/s41417-021-00399-1 |
Ejemplares similares
-
Gene Therapy Correction of Aldehyde Dehydrogenase 2 Deficiency
por: Matsumura, Yuki, et al.
Publicado: (2019) -
Gene Therapy to Treat Osteopenia Associated With Chronic Ethanol Consumption and Aldehyde Dehydrogenase 2 Deficiency
por: Camilleri, Anna E, et al.
Publicado: (2023) -
Targeting aldehyde dehydrogenase for prostate cancer therapies
por: Ma, Miao, et al.
Publicado: (2022) -
Update on the aldehyde dehydrogenase gene (ALDH) superfamily
por: Jackson, Brian, et al.
Publicado: (2011) -
The Aldehyde Dehydrogenase Gene Superfamily Resource Center
por: Black, William, et al.
Publicado: (2009)